Waiver Details and Legal Basis

On June 30, 2025 the President invoked section 307(d)(1)(B) of the Chemical and Biological Weapons Control and Warfare Elimination Act of 1991 (22 U.S.C. 5605(d)(1)(B)) to declare a fundamental change in the leadership and policies of the Syrian Arab Republic and to waive all sanctions imposed for the Assad regime’s use of chemical weapons, except for the restriction on arms sales and arms‑sales financing [1]. The waiver was formalized on August 20, 2026 when the Under Secretary for Arms Control and Nonproliferation certified that maintaining the two remaining restrictions was essential to United States national security, thereby leaving only the arms‑sales ban in place [1].

The legal framework requires a presidential determination of a “fundamental change” before any waiver can be issued, and the Act specifically targets sanctions related to chemical and biological weapons proliferation [1]. The original sanctions were imposed in response to the Assad government’s documented use of chemical agents against its own population, a policy the administration now deems altered sufficiently to merit relief, albeit with a narrow carve‑out for weapons transfers [1].

Strategic Logic Behind Waiver

The administration’s logic rests on leveraging sanctions relief as a diplomatic incentive while preserving a critical lever of pressure through the arms‑sales prohibition. By removing economic and financial constraints but keeping the military‑export ban, Washington signals willingness to engage Syria on reconstruction and regional cooperation without enabling a rapid buildup of Syrian conventional capabilities [1]. This calibrated approach reflects a national‑security assessment that the benefits of re‑integration outweigh the risks of a partially open Syrian market [1].

The decision also acknowledges that broad sanctions have had limited impact on altering Syrian policy, prompting a shift toward conditional engagement predicated on observable leadership changes. Retaining the arms‑sales restriction serves both as a safeguard against destabilizing re‑armament and as a bargaining chip for future negotiations on compliance with chemical‑weapons norms [1].

Regional and Policy Implications

In the Levant, the partial waiver could encourage Damascus to cooperate with neighboring states on issues such as border security, refugee repatriation, and counter‑terrorism, potentially contributing to a modest de‑escalation of long‑standing tensions. However, the continued arms‑sales ban ensures that any Syrian military resurgence remains capped, limiting Tehran’s ability to exploit Syrian capabilities as a proxy within the regional balance of power [1].

Beyond the Middle East, the waiver illustrates a willingness by the United States to adapt the 1991 Act’s punitive mechanisms to evolving political realities, setting a precedent for future sanctions relief tied to regime change narratives. This flexibility may influence how Washington structures sanctions in other conflict zones, signaling that relief is possible when a clear shift in leadership and policy is documented and deemed in the national interest [1].

Unresolved Issues and Signals

The record does not specify monitoring mechanisms to verify that Syria’s leadership continues to uphold the chemical‑weapons commitments that prompted the original sanctions, leaving a gap in how compliance will be assessed moving forward [1]. Likewise, the criteria for lifting the remaining arms‑sales restriction remain undefined, creating uncertainty about the conditions under which full normalization could occur.

Future presidential determinations that the “fundamental change” has reversed, or a new assessment by the Under Secretary that the arms‑sales ban no longer serves national‑security interests, would likely trigger a reinstatement of the full sanctions regime. Close observation of Syrian diplomatic behavior, any resurgence of chemical‑weapon use, and shifts in U.S. strategic priorities will be the primary indicators of whether the waiver will expand or be rolled back.